Is Radioembolization (Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis
This study compares radioembolization (90Y) versus doxorubicin drug eluting beads (DEBDOX) in the treatment of unresectable hepatocellular carcinoma with portal vein thrombosis.
Source: Surgical Oncology - Category: Surgery Authors: Olaguoke Akinwande, Daniel Kim, Jacob Edwards, Russell Brown, Prejesh Philips, Charles Scoggins, Robert C.G. Martin Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Study | Surgery | Thrombosis